GBIO logo

Generation Bio Co (GBIO) Stock

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

12 June 2020

Indexes:

Not included

Description:

Generation Bio Co is a biotechnology company focused on developing innovative gene therapies. They aim to treat genetic diseases by using their unique platform to deliver genes directly to patients' cells, offering potential long-term solutions for conditions that currently have limited treatment options.

Events Calendar

Earnings

Next earnings date:

Mar 06, 2025

Recent quarterly earnings:

Nov 06, 2024

Recent annual earnings:

Mar 06, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

23 Oct '24 Needham
Buy
08 Aug '24 Wedbush
Outperform
08 Aug '24 Needham
Buy
14 May '24 Wedbush
Outperform
14 May '24 Needham
Buy
10 Apr '24 Needham
Buy
07 Mar '24 Wedbush
Outperform
07 Mar '24 Needham
Buy
10 Nov '23 Wedbush
Outperform
23 Oct '23 JMP Securities
Market Perform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress
GBIO
globenewswire.com22 October 2024

CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today presented data on its cell-targeted lipid nanoparticle (ctLNP) and immune-quiet DNA (iqDNA) platforms at the European Society of Gene and Cell Therapy (ESGCT) 31st Annual Congress.

Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
GBIO
Zacks Investment Research13 May 2024

GBIO reported a quarterly loss of $1.12 per share, which was higher than the Zacks Consensus Estimate of a loss of $0.36. This is an increase from the loss of $0.53 per share reported in the same quarter last year.

Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates
Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates
Generation Bio Co. (GBIO) Reports Q4 Loss, Lags Revenue Estimates
GBIO
Zacks Investment Research06 March 2024

Generation Bio Co. (GBIO) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to loss of $0.55 per share a year ago.

Generation Bio to Present at the 2024 TD Cowen Health Care Conference
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
Generation Bio to Present at the 2024 TD Cowen Health Care Conference
GBIO
GlobeNewsWire27 February 2024

CAMBRIDGE, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will present at the 2024 TD Cowen Health Care Conference on Tuesday, March 5, 2024 at 9:10 a.m. ET in Boston.

Generation Bio Co. (GBIO) Reports Q1 Loss, Misses Revenue Estimates
Generation Bio Co. (GBIO) Reports Q1 Loss, Misses Revenue Estimates
Generation Bio Co. (GBIO) Reports Q1 Loss, Misses Revenue Estimates
GBIO
Zacks Investment Research10 May 2023

Generation Bio Co. (GBIO) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.39. This compares to loss of $0.61 per share a year ago.

Generation Bio to Present at the JMP Securities Life Sciences Conference
Generation Bio to Present at the JMP Securities Life Sciences Conference
Generation Bio to Present at the JMP Securities Life Sciences Conference
GBIO
GlobeNewsWire09 May 2023

CAMBRIDGE, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Matt Norkunas, M.D., chief financial officer, will present at the JMP Securities Life Sciences on Tuesday, May 16, 2023 at 1:00 p.m. EST in New York.

FAQ

  • What is the primary business of Generation Bio Co?
  • What is the ticker symbol for Generation Bio Co?
  • Does Generation Bio Co pay dividends?
  • What sector is Generation Bio Co in?
  • What industry is Generation Bio Co in?
  • What country is Generation Bio Co based in?
  • When did Generation Bio Co go public?
  • Is Generation Bio Co in the S&P 500?
  • Is Generation Bio Co in the NASDAQ 100?
  • Is Generation Bio Co in the Dow Jones?
  • When was Generation Bio Co's last earnings report?
  • When does Generation Bio Co report earnings?
  • Should I buy Generation Bio Co stock now?

What is the primary business of Generation Bio Co?

Generation Bio Co is a biotechnology company focused on developing innovative gene therapies. They aim to treat genetic diseases by using their unique platform to deliver genes directly to patients' cells, offering potential long-term solutions for conditions that currently have limited treatment options.

What is the ticker symbol for Generation Bio Co?

The ticker symbol for Generation Bio Co is NASDAQ:GBIO

Does Generation Bio Co pay dividends?

No, Generation Bio Co does not pay dividends

What sector is Generation Bio Co in?

Generation Bio Co is in the Healthcare sector

What industry is Generation Bio Co in?

Generation Bio Co is in the Biotechnology industry

What country is Generation Bio Co based in?

Generation Bio Co is headquartered in United States

When did Generation Bio Co go public?

Generation Bio Co's initial public offering (IPO) was on 12 June 2020

Is Generation Bio Co in the S&P 500?

No, Generation Bio Co is not included in the S&P 500 index

Is Generation Bio Co in the NASDAQ 100?

No, Generation Bio Co is not included in the NASDAQ 100 index

Is Generation Bio Co in the Dow Jones?

No, Generation Bio Co is not included in the Dow Jones index

When was Generation Bio Co's last earnings report?

Generation Bio Co's most recent earnings report was on 6 November 2024

When does Generation Bio Co report earnings?

The next expected earnings date for Generation Bio Co is 6 March 2025

Should I buy Generation Bio Co stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions